170 related articles for article (PubMed ID: 1710646)
1. Immune responses in mice following immunization with chimeric synthetic peptides representing B and T cell epitopes of measles virus proteins.
Partidos CD; Stanley CM; Steward MW
J Gen Virol; 1991 Jun; 72 ( Pt 6)():1293-9. PubMed ID: 1710646
[TBL] [Abstract][Full Text] [Related]
2. Protection against morbillivirus-induced encephalitis by immunization with a rationally designed synthetic peptide vaccine containing B- and T-cell epitopes from the fusion protein of measles virus.
Obeid OE; Partidos CD; Howard CR; Steward MW
J Virol; 1995 Mar; 69(3):1420-8. PubMed ID: 7531779
[TBL] [Abstract][Full Text] [Related]
3. The influence of orientation and number of copies of T and B cell epitopes on the specificity and affinity of antibodies induced by chimeric peptides.
Partidos C; Stanley C; Steward M
Eur J Immunol; 1992 Oct; 22(10):2675-80. PubMed ID: 1382995
[TBL] [Abstract][Full Text] [Related]
4. The effect of orientation of epitopes on the immunogenicity of chimeric synthetic peptides representing measles virus protein sequences.
Partidos C; Stanley C; Steward M
Mol Immunol; 1992 May; 29(5):651-8. PubMed ID: 1374843
[TBL] [Abstract][Full Text] [Related]
5. The effects of a flanking sequence on the immune response to a B and a T cell epitope from the fusion protein of measles virus.
Partidos CD; Steward MW
J Gen Virol; 1992 Aug; 73 ( Pt 8)():1987-94. PubMed ID: 1379626
[TBL] [Abstract][Full Text] [Related]
6. Analysis of the neutralizing antibody response to the measles virus using synthetic peptides of the haemagglutinin protein.
Muller CP; Schroeder T; Tu R; Brons NH; Jung G; Schneider F; Wiesmüller KH
Scand J Immunol; 1993 Nov; 38(5):463-71. PubMed ID: 7694357
[TBL] [Abstract][Full Text] [Related]
7. Prediction and identification of a T cell epitope in the fusion protein of measles virus immunodominant in mice and humans.
Partidos CD; Steward MW
J Gen Virol; 1990 Sep; 71 ( Pt 9)():2099-105. PubMed ID: 2212993
[TBL] [Abstract][Full Text] [Related]
8. Antibody responses to non-immunogenic synthetic peptides induced by co-immunization with immunogenic peptides.
Partidos CD; Obeid OE; Steward MW
Immunology; 1992 Oct; 77(2):262-6. PubMed ID: 1385315
[TBL] [Abstract][Full Text] [Related]
9. Identification of helper T cell antigenic sites in mice from the haemagglutinin glycoprotein of measles virus.
Obeid OE; Partidos CD; Steward MW
J Gen Virol; 1993 Dec; 74 ( Pt 12)():2549-57. PubMed ID: 7506296
[TBL] [Abstract][Full Text] [Related]
10. Human T-lymphotropic virus type 1 peptides in chimeric and multivalent constructs with promiscuous T-cell epitopes enhance immunogenicity and overcome genetic restriction.
Lairmore MD; DiGeorge AM; Conrad SF; Trevino AV; Lal RB; Kaumaya PT
J Virol; 1995 Oct; 69(10):6077-89. PubMed ID: 7545241
[TBL] [Abstract][Full Text] [Related]
11. Peptide vaccines incorporating a 'promiscuous' T-cell epitope bypass certain haplotype restricted immune responses and provide broad spectrum immunogenicity.
Kaumaya PT; Kobs-Conrad S; Seo YH; Lee H; VanBuskirk AM; Feng N; Sheridan JF; Stevens V
J Mol Recognit; 1993 Jun; 6(2):81-94. PubMed ID: 7508238
[TBL] [Abstract][Full Text] [Related]
12. Peptide-induced memory (IgG) response, cross-reactive with native proteins, requires covalent linkage of a specific B cell epitope with a T cell epitope.
Zegers ND; van Holten C; Claasen E; Boersma WJ
Eur J Immunol; 1993 Mar; 23(3):630-4. PubMed ID: 7680611
[TBL] [Abstract][Full Text] [Related]
13. The molecular basis of virus crossreactivity and neutralisation after immunisation with optimised chimeric peptides mimicking a putative helical epitope of the measles virus hemagglutinin protein.
El Kasmi KC; Theisen D; Brons NH; Muller CP
Mol Immunol; 1998 Oct; 35(14-15):905-18. PubMed ID: 9881686
[TBL] [Abstract][Full Text] [Related]
14. Priming of measles virus-specific CTL responses after immunization with a CTL epitope linked to a fusogenic peptide.
Partidos CD; Vohra P; Steward MW
Virology; 1996 Jan; 215(1):107-10. PubMed ID: 8553582
[TBL] [Abstract][Full Text] [Related]
15. Protection against measles virus-induced encephalitis by anti-mimotope antibodies: the role of antibody affinity.
Olszewska W; Obeid OE; Steward MW
Virology; 2000 Jun; 272(1):98-105. PubMed ID: 10873752
[TBL] [Abstract][Full Text] [Related]
16. Protective immunity provided by HLA-A2 epitopes for fusion and hemagglutinin proteins of measles virus.
Oh S; Stegman B; Pendleton CD; Ota MO; Pan CH; Griffin DE; Burke DS; Berzofsky JA
Virology; 2006 Sep; 352(2):390-9. PubMed ID: 16781760
[TBL] [Abstract][Full Text] [Related]
17. Neutralization of measles virus wild-type isolates after immunization with a synthetic peptide vaccine which is not recognized by neutralizing passive antibodies.
El Kasmi KC; Fillon S; Theisen DM; Hartter H; Brons NH; Muller CP
J Gen Virol; 2000 Mar; 81(Pt 3):729-35. PubMed ID: 10675410
[TBL] [Abstract][Full Text] [Related]
18. Structural requirements for synthetic immunogens to induce measles virus specific CTL responses.
Partidos CD; Delmas A; Steward MW
Mol Immunol; 1996 Nov; 33(16):1223-9. PubMed ID: 9129158
[TBL] [Abstract][Full Text] [Related]
19. Analysis of the antigenic profile of measles virus haemagglutinin in mice and humans using overlapping synthetic peptides.
Obeid OE; Partidos CD; Steward MW
Virus Res; 1994 Apr; 32(1):69-84. PubMed ID: 7518172
[TBL] [Abstract][Full Text] [Related]
20. Immunogenicity of a chimeric peptide corresponding to T helper and B cell epitopes of the Chlamydia trachomatis major outer membrane protein.
Su H; Caldwell HD
J Exp Med; 1992 Jan; 175(1):227-35. PubMed ID: 1370528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
